ED
AGN

Exane Derivatives’s Allergan plc AGN Stock Holding History

Exane Derivatives’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2
Closed -$354 – 756
2020
Q1 		$354 Hold
2
– – ﹤0.01% 628
2019
Q4 		$388 Hold
2
– – ﹤0.01% 631
2019
Q3 		$337 Sell
2
-26,438
-100% -$4.31M ﹤0.01% 610
2019
Q2 		$4.43M Buy
26,440
+25,679
+3,374% +$3.56M 0.78% 23
2019
Q1 		$111K Sell
761
-1,552
-67% -$225K 0.02% 285
2018
Q4 		$309K Buy
2,313
+1,821
+370% +$299K 0.06% 210
2018
Q3 		$93.9K Sell
492
-15,882
-97% -$2.92M 0.02% 326
2018
Q2 		$2.73M Buy
+16,374
New +$2.63M 0.46% 39
2018
Q1 		– Sell
-7,547
Closed -$1.24M – 667
2017
Q4 		$1.24M Buy
7,547
+5,883
+354% +$1.06M 0.21% 87
2017
Q3 		$341K Buy
1,664
+915
+122% +$213K 0.06% 158
2017
Q2 		$182K Sell
749
-1,361
-65% -$320K 0.04% 207
2017
Q1 		$504K Buy
2,110
+1,384
+191% +$322K 0.11% 130
2016
Q4 		$152K Buy
726
+725
+72,500% +$150K 0.03% 213
2016
Q3 		$230 Buy
+1
New +$244 ﹤0.01% 509
2015
Q2 		– Sell
-74,025
Closed -$22M – 568
2015
Q1 		$22M Buy
74,025
+73,863
+45,594% +$21.1M 2.43% 11
2014
Q4 		$41.7K Buy
+162
New +$40.5K 0.01% 341

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Exane Derivatives's AGN Position: Q2 2020 in Review

Exane Derivatives sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2 shares — an estimated $354 sold.

Exane Derivatives first reported a position in AGN in Q4 2014 and held it in 16 quarters. The position peaked at $22M in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Exane Derivatives reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Exane Derivatives sold 2 Allergan plc shares in Q2 2020, an estimated $354.
  • Exane Derivatives first reported a position in Allergan plc in Q4 2014 and held it in 16 quarters.
  • Exane Derivatives's Allergan plc position peaked at $22M in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Exane Derivatives's 13F filing for Q2 2020, filed 10 Jul 2020.